1-10 of 10
Kelly M Grotzinger
Close
Sort by
Journal Articles

Improvements in Patient Health-Related Quality of Life (HRQoL) with Clinical Efficacy in Patients Treated with Eltrombopag: Final Results from the Long-Term, Open-Label Extend Study

Mansoor N. Saleh, James B. Bussel, MD, Abderrahim Khelif, Paul Burgess, Ali El-Ali, Anuja Roy, Victoria Barghout, Mei Sheng Duh, Kelly M. Grotzinger, Abdulgabar Salama
Journal: Blood
Blood (2016) 128 (22): 3742.
https://doi.org/10.1182/blood.V128.22.3742.3742
Published: 2016
Journal Articles

Patient-Reported Health-Related Quality of Life Improves over Time in Patients with Chronic Immune Thrombocytopenia Receiving Long-Term Treatment with Eltrombopag

Abderrahim Khelif, Mansoor N. Saleh, Abdulgabar Salama, Paul Burgess, Maria do Socorro O Portella, Anuja Roy, Victoria Barghout, Jasmina I. Ivanova, Kelly M. Grotzinger, James B. Bussel, MD
Journal: Blood
Blood (2016) 128 (22): 3750.
https://doi.org/10.1182/blood.V128.22.3750.3750
Published: 2016
Journal Articles

Health-Related Quality of Life in Children with Chronic Immune Thrombocytopenia Treated with Eltrombopag in the PETIT Study.

Victor S. Blanchette, FRCP, Kelly M Grotzinger, Lisa Marcello, BA, MS, Kalpana Bakshi, BS, MS, Andres Brainsky, MD
Journal: Blood
Blood (2012) 120 (21): 2197.
https://doi.org/10.1182/blood.V120.21.2197.2197
Published: 2012
Journal Articles

Dynamics of Improvement in Health-Related Quality of Life (HRQoL) with Long-Term Eltrombopag Treatment in Adults with Chronic Immune Thrombocytopenia (ITP) in EXTEND.

Kelly M Grotzinger, James B Bussel, MD, Mansoor N Saleh, MD, Christine Bieri, MBA, Yuliya Orlova, Andres Brainsky, MD
Journal: Blood
Blood (2012) 120 (21): 2199.
https://doi.org/10.1182/blood.V120.21.2199.2199
Published: 2012
Journal Articles

Patient Reported Outcomes Comparison of Chronic Immune Thrombocytopenia (ITP) Patients Switched to Promacta and Nplate

David J. Kuter, MD, DPhil, Feng Wang, Katie L Dawson, MD, MPH, Kelly M. Grotzinger, PhD, Cynthia P Macahilig
Journal: Blood
Blood (2011) 118 (21): 2220.
https://doi.org/10.1182/blood.V118.21.2220.2220
Published: 2011
Journal Articles

Therapy for Chronic ITP - the Patients' Perspective: US and Germany.

Axel C. Matzdorff, MD, PhD, Gabriele Arnold, Simone S. Hummler, MD, Kelly M. Grotzinger, Ruslan V. Horblyuk, MBA
Journal: Blood
Blood (2009) 114 (22): 4451.
https://doi.org/10.1182/blood.V114.22.4451.4451
Published: 2009
Journal Articles

Risk Factors for Transition From Normal Platelet Count to Severe Thrombocytopenia Among Patients with Chronic Liver Disease.

Elizabeth V Lawler, DSc, MPH, Jennifer R Fonda, MA, Ruslan V. Horblyuk, MBA, Kelly M. Grotzinger, PhD, Cara McLaughlin, MD, Tim Morgan, MD, Marcos Pedrosa, MD, David R Gagnon, MD, MPH, PhD
Journal: Blood
Blood (2009) 114 (22): 3518.
https://doi.org/10.1182/blood.V114.22.3518.3518
Published: 2009
Journal Articles

Time to Splenectomy Failure in Patients with Recurrent or Refractory Chronic Immune Thrombocytopenic Purpura.

Gregory Cheng, Terry Gernsheimer, MD, Harold J. Olney, MD, CM, James B. Bussel, MD, Palvi Shah, Andres Brainsky, Kelly M. Grotzinger, Manuel Aivado
Journal: Blood
Blood (2009) 114 (22): 3522.
https://doi.org/10.1182/blood.V114.22.3522.3522
Published: 2009
Journal Articles

Patients Are Willing to Trade off Efficacy, Safety, and Administration Attributes of Chronic Idiopathic Purpura (ITP) Therapy: Results from a Large North American Discrete Choice Study

Kelly M Grotzinger, F. Reed Johnson, A. Brett Hauber, Semra OĢˆzdemir, Mohan V Bala
Journal: Blood
Blood (2008) 112 (11): 669.
https://doi.org/10.1182/blood.V112.11.669.669
Published: 2008
Journal Articles

Study of Treatment Patterns and Consequences of Immune Thrombocytopenic Purpura (ITP).

Maxine D. Fisher, PhD, Grace Yang, MPA, Lauren P. Burawski, MA, Kelly M. Grotzinger, PhD, MBA, Andrew B. Provan, MD, John J. Barron, PharmD
Journal: Blood
Blood (2005) 106 (11): 5593.
https://doi.org/10.1182/blood.V106.11.5593.5593
Published: 2005